Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation. [electronic resource]
Producer: 20180806Description: 946-954 p. digitalISSN:- 1862-1783
- Aged
- Albumins -- analysis
- Anticoagulants -- therapeutic use
- Atrial Fibrillation -- drug therapy
- Catheter Ablation -- adverse effects
- Female
- Follow-Up Studies
- Globulins -- analysis
- Hemorrhage -- prevention & control
- Humans
- Lipoproteins, HDL -- blood
- Male
- Middle Aged
- Patient Safety
- Prevalence
- Prospective Studies
- Rivaroxaban -- therapeutic use
- Stroke -- prevention & control
- Thromboembolism -- prevention & control
- Warfarin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.